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obinson and Abdel-Motagally (1)
compared their ﬁndings from
FINDRISC, an individual study, to
our summary estimates from a systematic
review (2) and concluded that our A1C
review overestimated future diabetes
incidence. Although their ﬁndings add
to our understanding of the A1C level–
incident diabetes relationship, their con-
clusion was based on comparing a single
studywithasummaryestimatefrommul-
tiple studies. Our systematic review
summarized a heterogeneous set of stud-
ies in which the annualized diabetes in-
cidence ranged from 0.1% at A1C ,5.0%
to 54.1% at A1C $6.1%. The ﬁndings of
Robinson and Abdel-Motagally were ac-
tually quite consistent with some of the
individual studies in our review, particu-
larly Droumaguet et al. (3). In fact, most
studies included in our review had a
higher relative risk across A1C strata
and a higher absolute risk for A1C .6%
than those in the study by Robinson and
Abdel-Motagally.Forexample,forA1Cin
the 5.5–5.9% and 6.0–6.5% ranges, they
found, respectively, incidences of 6% and
9%. For the same A1C, Pradhan et al. (4)
found a respective incidence of 16% and
45.5%. Although a single outlying study
can bias a systematic review, the sensitiv-
ity analyses we conducted demonstrated
thatourresultsremainedconsistentwhen
any single study was eliminated, indicat-
ing that our ﬁndings were not driven by a
single outlying study.
Selvin et al. (5) recently examined the
relationship between A1C levels and fu-
tureriskofdiabetesandreportedﬁndings
similar to but a bit larger than ours. Thus,
instead of concluding that our review
overestimates incidence rates, one should
conclude that variation exists between
studies of the relationship between A1C
and diabetes incidence. Finally, we rean-
alyzed our data, including the results of
Robinson and Abdel-Motagally and the
results of Selvin et al. We found very little
differenceintheresultingincidencecurve
(data not reported).
We appreciated Robinson and col-
leagues’ effort in exploring the relation-
ship between A1C level and future risk
of diabetes.
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